Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asan Pharm is a South Korea-based diagnostics company focused on in vitro diagnostic reagents, diagnostic devices, molecular diagnostics, transport media, and culture media. The company markets a broad portfolio of branded products, including the Asan Easy Test rapid diagnostics line and Asan qPCR Test assays for infectious diseases such as dengue, syphilis, COVID-19, influenza, and other pathogen panels. Its affiliated Asan Biotech Institute develops recombinant antigens, antibodies, molecular diagnostic products, and immunosensors, supporting in-house R&D and manufacturing. The business appears to be primarily commercial-stage rather than a therapeutic drug developer, with operations spanning headquarters in Seoul and manufacturing/R&D sites in Gyeonggi-do.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asan Pharm.